Bruce C. Conway

Director/Board Member en Trigemina, Inc. .

72 años

Health Technology

Electronic Technology

Perfil

Bruce C.
Conway is currently a Director at Trigemina, Inc. He was previously a Director at Whitehall Corp.
and an Independent Director at Clearpoint Neuro, Inc. from 2011 to 2013.

Cargos activos de Bruce C. Conway

Empresas	Cargo	Inicio
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Director/Board Member	-

Todos los cargos activos de Bruce C. Conway

Antiguos cargos conocidos de Bruce C. Conway.

Empresas	Cargo	Fin
CLEARPOINT NEURO, INC.	Director/Board Member	12/04/2013
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Director/Board Member	-

Ver el detalle de la experiencia de Bruce C. Conway.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Bruce C. Conway.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
CLEARPOINT NEURO, INC.	Health Technology

Empresas privadas	2
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Electronic Technology
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Health Technology